News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New tests select patients who could live for nearly a year longer on targeted bowel cancer drug
Giving patients with bowel cancer an MRI scan and a blood test could pick out those who would benefit from a targeted cancer treatment, a new study reports.
Scientists find new method to target hard-to-treat head and neck cancers
An MRI technique could help doctors predict survival and develop improved treatments by identifying areas of fluctuating oxygen levels in head and neck tumours.
Testing for immune ‘hotspots’ can predict risk that breast cancer will return
Scientists have developed a new test that can pick out women at high risk of relapsing from breast cancer within 10 years of diagnosis.
Targeted radiotherapy limits side effects of breast cancer treatment
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, according to trial results published in The Lancet.
Structure of key complex behind DNA transcription uncovered
Researchers have determined the structure of a molecular protein complex that helps DNA to be read and its instructions carried out.
Discovery Club learns of “lost tribe” of young adult cancer patients
Members of our Discovery Club gathered at Chelsea Physic Garden in London earlier this month to learn about the unique challenges posed in treating cancer in teens and young adults.
New computer program makes it easier to track living cells
Researchers have developed a computer program - NucliTrack - to more efficiently track the trajectory of moving cells.
Scientists discover new line of attack against cancer
Scientists have made the surprise discovery of an exciting new way of blocking a crucial cancer protein that has proved extremely difficult to target.
Pioneering leukaemia and evolution researcher – Professor Mel Greaves – wins prestigious Royal Society award
Professor Mel Greaves has been awarded The Royal Society’s prestigious Royal Medal in recognition of his research, which has dramatically improved our understanding of childhood leukaemia.
ICR commended for plans to work with commercial partners
The ICR has been commended for its approach to transforming its discoveries into new treatments for people with cancer by working with industry.
World-leading cancer researchers first in UK to receive NovaSeq - the latest genome sequencing technology
UK scientists now have access to a new kind of next-generation genome sequencer - NovaSeq - which could revolutionise their research to defeat cancer.
Scientists call for better use of chemical tools to improve cancer drug discovery
Chemical tools used in cancer research need to be selected more carefully, researchers have warned.
